Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-361096

See Remarks sold 69,076 shares at an average $15.75 ($1,088,273)

  • See Remarks acquired 50,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kirn David See Remarks 2026-08-19 Option exercise 10b5-1 +50,000 $4.14 $207,000 894,895 D: show line 1 in the form
Kirn David See Remarks 2026-08-19 Sale 10b5-1 −43,149 $15.36 $662,622 851,746 D: show line 2 in the form
Kirn David See Remarks 2026-08-19 Sale 10b5-1 −25,927 $16.42 $425,651 825,819 D: show line 3 in the form
Open-market sales · 69,076 sh · avg $15.75 · $1,088,273

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kirn David See Remarks 2026-08-19 Option exercise · Stock Option (Right to Buy) 10b5-1 −50,000 217,500 D: show line 4 in the form
Loading xslF345X06/ownership.xml…